United States· US:62670-6864_38d0d1d3-0655-99b6-e063-6394a90ac92d
Bath and Body Works SPF
A medicinal product containing octocrylene; avobenzone; homosalate; octisalate, registered in United States by Bath & Body Works, Inc..
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- OCTOCRYLENE; AVOBENZONE; HOMOSALATE; OCTISALATE
- Manufacturer
- Bath & Body Works, Inc.
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 2
- ndc1162670-6864-0
- ndc116267068640103 mg in 1 BOTTLE (62670-6864-0)
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/c1e0701b-5a0a-4b84-aba4-ca99ecffedb2 GET /v1/drugs/c1e0701b-5a0a-4b84-aba4-ca99ecffedb2?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "TOPICAL",
"source": "ndc",
"strength": "10; 3; 10; 5",
"substance": "OCTOCRYLENE; AVOBENZONE; HOMOSALATE; OCTISALATE",
"productndc": "62670-6864",
"dosage_form": "GEL",
"dea_schedule": null,
"strength_unit": "mg/100mg; mg/100mg; mg/100mg; mg/100mg",
"application_number": "M020",
"marketing_category": "OTC MONOGRAPH DRUG"
}See everything about octocrylene; avobenzone; homosalate; octisalate.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.